Particularly, TREML-1 can enhance the calcium signalling in an SHP2 (PTPN11)-dependent manner, whereas some genetic variant of TREML-2 have been identified to be protective for Alzheimer’s disease, contrary to TREM-2 genetic variants. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.